Skip to main content

Table 2 Participants’ characteristics

From: Walking-adaptability therapy after stroke: results of a randomized controlled trial

  C-Mill therapy
(n = 16)
FALLS program (n = 17) p value
Gender (female/male) 9/7 5/12 0.13c
Age at intake (years) 52 ± 13 59 ± 10 0.13a
Height (cm) 171 ± 10 175 ± 7 0.40a
Body mass (kg) 76 ± 13 80 ± 14 0.18a
Time since stroke at intake (months, median) 46 (6–372) 20 (13–110) 0.05c
Side of lesion (left/right) 9/7 8/9 0.66c
Functional Ambulation Category (FAC) at intake (1–5, median) 5 (4–5) 5 (4–5) 0.99c
Berg Balance Scale (BBS) (0–56, median) 55 (39–56) 53 (46–56) 0.58c
Mini-Mental State Examination MMSE (0–30, median) 29 (26–30) 28 (22–30) 0.63c
Assistive device (none/(k)evo/walking cane) 6/4/6 10/3/4 0.22c
Level of activity (1–5 days a week at least 30 min moderate active) 1 (0–5) 2 (0–5) 0.31c
Falls past year (n, %) 8, 50% 13, 76% 0.12b
Fear of falling (1 (no fear of falling)–10 (extreme fear of falling)) 5 (1–9) 3 (1–10) 0.31c
Living situation (independently/independently with help) 3/13 6/11 0.42c
Comorbidities (n, %) 9, 57% 10, 59% 0.58b
  1. p values were obtained using aIndependent t-test, bFisher’s exact test, or cMann-Whitney U test. Tendencies towards significant differences are presented in italic (0.05 < p < 0.075)